Innovation

New Serotonin Transporter Imaging Agents

University of Pennsylvania
posted on 08/26/2009

New Serotonin Transporter Imaging Agents


Innovation Details
 

Detailed Description

Anxiety and depressive disorders have been associated with the level of serotonin in the brain. These disorders are typically treated by prescribing a selective serotonin reuptake inhibitor (SSRI). SSRI drugs (i.e., Prozacô) will bind with the serotonin

File Number: L1993 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Jacqueline Harris at University of Pennsylvania for more information.

Request more info via email request more info
People

Case Manager:

Jacqueline Harris Jacqueline Harris

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...